Literature Cited

  • 1
    Mostert B,Sleijfer S,Foekens JA,Gratama JW. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 2009; 35: 463474.
  • 2
    Paterlini-Brechot P,Benali NL. Circulating tumor cells (CTC) detection: Clinical impact and future directions. Cancer Lett 2007; 253: 180204.
  • 3
    Miller MC,Doyle GV,Terstappen LW. Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010; doi:10.1155/2010/617421.
  • 4
    Serrano Fernádez MJ,Alvarez Merino JC,Martínez Zubiaurre I,Fernández García A,Sánchez Rovira P,Lorente Acosta JA. Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours. Clin Transl Oncol 2009; 11: 659668.
  • 5
    Bertazza L,Mocellin S,Nitti D. Circulating tumor cells in solid cancer: Tumor marker of clinical relevance? Curr Oncol Rep 2008; 10: 137146.
  • 6
    Allan AL,Keeney M. Circulating tumor cell analysis: Technical and statistical considerations for application to the clinic. J Oncol 2010; doi:10.1155/2010/426218.
  • 7
    Alunni-Fabbroni M,Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods 2010; 50: 289297.
  • 8
    Baeuerle PA,Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96: 417423.
  • 9
    van der Vaart M,Pretorius PJ. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin Biochem 2010; 43: 2636.
  • 10
    Van der Auwera I,Peeters D,Benoy IH,Elst HJ,Van Laere SJ,Prové A,Maes H,Huget P,van Dam P,Vermeulen PB,Dirix LY. Circulating tumour cell detection: A direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 2010; 102: 276284.
  • 11
    Kojima T,Hashimoto Y,Watanabe Y,Kagawa S,Uno F,Kuroda S,Tazawa H,Kyo S,Mizuguchi H,Urata Y,Tanaka N,Fujiwara T. A simple biological imaging system for detecting viable human circulating tumor cells. J Clin Invest 2009; 119: 31723181.
  • 12
    Fong SM,Lee MK,Adusumilli PS,Kelly KJ. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood. Surgery 2009; 146: 498505.
  • 13
    Hu Y,Fan L,Zheng J,Cui R,Liu W,He Y,Li X,Huang S. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels. Cytometry A 2010; 77A: 213219.
  • 14
    Wang L,Wang Y,Liu Y,Cheng M,Wu X,Wei H. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: Relevance for circulating tumor cell detection. J Exp Clin Cancer Res 2009; 28: 57.
  • 15
    Allan AL,Vantyghem SA,Tuck AB,Chambers AF,Chin-Yee IH,Keeney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A 2005; 65A: 414.
  • 16
    Cruz I,Ciudad J,Cruz JJ,Ramos M,Gómez-Alonso A,Adansa JC,Rodríguez C,Orfao A. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 2005; 123: 6674.
  • 17
    Subarsky P,Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003; 20: 237250.
  • 18
    Brooks SA,Lomax-Browne HJ,Carter TM,Kinch CE,Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112: 325.
  • 19
    Wlodkowic D,Skommer J,Darzynkiewicz Z. Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry A 2010; 77A: 591606.
  • 20
    Gião MS,Wilks SA,Azevedo NF,Vieira MJ,Keevil CW. Validation of SYTO 9/propidium iodide uptake for rapid detection of viable but noncultivable Legionella pneumophila. Microb Ecol 2009; 58: 5662.
  • 21
    Schmelzer E,Zhang L,Bruce A,Wauthier E,Ludlow J,Yao HL,Moss N,Melhem A,McClelland R,Turner W,Kulik M,Sherwood S,Tallheden T,Cheng N,Furth ME,Reid LM. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204: 19731987.
  • 22
    Witzig TE,Bossy B,Kimlinger T,Roche PC,Ingle JN,Grant C,Donohue J,Suman VJ,Harrington D,Torre-Bueno J,Bauer KD. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002; 8: 10851091.
  • 23
    Campos M,Prior C,Warleta F,Zudaire I,Ruíz-Mora J,Catena R,Calvo A,Gaforio JJ. Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques. J Histochem Cytochem 2008; 56: 667675.
  • 24
    Königsberg R,Gneist M,Jahn-Kuch D,Pfeiler G,Hager G,Hudec M,Dittrich C,Zeillinger R. Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods. Cancer Lett 2010; 293: 117123.
  • 25
    Liu MP,Handschumacher RE. Tamoxifen induces Na+ -dependent uridine transport and dome formation in a human breast tumor cell line. Cancer J Sci Am 1995; 1: 210214.
  • 26
    Willipinski-Stapelfeldt B,Riethdorf S,Assmann V,Woelfle U,Rau T,Sauter G,Heukeshoven J,Pantel K. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005; 11: 80068014.
  • 27
    Antolovic D,Galindo L,Carstens A,Rahbari N,Büchler MW,Weitz J,Koch M. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol 2010; 10: 35.
  • 28
    Balzar M,Briaire-de Bruijn IH,Rees-Bakker HA,Prins FA,Helfrich W,de Leij L,Riethmüller G,Alberti S,Warnaar SO,Fleuren GJ,Litvinov SV. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001; 21: 25702580.
  • 29
    Nagrath S,Sequist LV,Maheswaran S,Bell DW,Irimia D,Ulkus L,Smith MR,Kwak EL,Digumarthy S,Muzikansky A,Ryan P,Balis UJ,Tompkins RG,Haber DA,Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 12351239.
  • 30
    Antolovic D,Galindo L,Carstens A,Rahbari N,Büchler MW,Weitz J,Koch M. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol 2010; doi:10.1186/1472–6750-10–35.
  • 31
    Vona G,Estepa L,Béroud C,Damotte D,Capron F,Nalpas B,Mineur A,Franco D,Lacour B,Pol S,Bréchot C,Paterlini-Bréchot P. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004; 39: 792797.
  • 32
    Horbinski C,Mojesky C,Kyprianou N. Live free or die. tales of homeless (Cells) in cancer. Am J Pathol 2010; 177: 10441052.
  • 33
    Vona G,Sabile A,Louha M,Sitruk V,Romana S,Schütze K,Capron F,Franco D,Pazzagli M,Vekemans M,Lacour B,Bréchot C,Paterlini-Bréchot P. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000; 156: 5763.
  • 34
    Gerges N,Rak J,Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010; 94: 4964.